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Image Guided RadioTherapy (IGRT) is currently considered the golden 
standard in radiotherapy. Especially IGRT is required for prostate 
cancer, as the prostate is a small organ, which can show large move-
ments and where the actual tumor inside the prostate is difficult to 
detect. Imaging in prostate cancer IGRT can be divided into (1) imag-
ing before treatment for patient selection and treatment planning, (2) 
imaging during treatment to compensate for movement and (3) imag-
ing after treatment to evaluate treatment success or to detect a local 
recurrence. 
1. Imaging before treatment consists of a CT-scan and an MRI scan for 
delineation and planning purposes. MRI has optimal soft-tissue con-
trast and adds to the CT delineation, especially as it is able to show 
the location of the tumor inside the prostate. MRI usually consists of 
both anatomical sequences (T1-, T2-weighted) and functional imaging, 
like perfusion (DCE-MRI), water diffusion (DWI), metabolites (MRS), 
and several other possibilities (Figure 1). As the information on the 
location of the tumor in most sequences does not overlap, decisions 
are required to delineate the tumor. Predictive models are currently 
developed to help this decision. For detection and possible treatment 
of regional metastases and / or bone metastases MRI and Choline-PET 
are currently investigated.  
2. Imaging during treatment is meant to compensate for movement. 
Visualization of gold fiducial markers can be used for this purpose, but 
also Cone-beam CT is commonly used. An MRI-linac is under develop-
ment. In brachytherapy, ultrasound is generally used for intra-fraction 
decisions. Currently, brachytherapy (HDR and LDR applications) is 
being developed in the MRI. 
3. Post-radiotherapy a Choline PET is used to detect local recurrences 
after pervious radiotherapy (brachytherapy or external beam). It has 
high sensitivity and specificity for this purpose. For re-treatment 
(salvage) purposes MRI, including DCE and DWI, seems required to 
determine the exact location. A possible salvage treatment will start 
the IGRT loop again with the first (1) imaging part: imaging before 
treatment for patient selection and planning. 
In IGRT for prostate cancer two issues are currently explored: focal 
therapy and extreme hypofractionation. These two issues have very 
high demands with regard to imaging, like spacial accuracy, detection 
accuracy, movements, deformation, a.o. 
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Several alternative ablative technologies, based on local temperature 
elevation, are used in medicine. They can be based on electromagnet-
ic waves in the microwave, optical, radio-frequency spectrum, or 
mechanical waves. If high spatial precision is required, High Intensity 
Focused Ultrasound (HIFU) is the only technology capable of achieving 
a local temperature increase deep inside the human body in a non-
invasive way. This presentation will deal mostly with HIFU technology. 
MRI guidance of the procedure allows in situ target definition and 
identification of nearby healthy tissue to be spared. In addition, MRI 
can be used to provide continuous temperature mapping during HIFU 
for spatial and temporal control of the heating procedure and predic-
tion of the final lesion based on the received thermal dose. The 
primary purpose of the development of MR guided HIFU was to 
achieve safe non-invasive tissue ablation.The technique has been 
tested extensively in preclinical studies, and is now accepted in the 
clinic for ablation of uterine fibroids, and for palliative treatment of 
painful bone metastases. MR guided HIFU for ablation shows concep-
tual similarities with radiation therapy. However, thermal damage 
generally shows threshold like behavior with necrosis above the 
critical thermal dose, and full recovery below. MR guided HIFU is 
being clinically evaluated in the cancer field for prostate, breast, 
liver, kidney and brain.The technology also shows great promise for a 
variety of advanced therapeutic methods such as gene and/or drug 
delivery.  
MR guided HIFU of mobile organs as kidney and liver is particularly 
challenging. Three central issues are addressed here together with 
preclinical validation: 
1) Rapid temperature mapping. Ideally, MR-Thermometry should 
achieve a sub-second temporal resolution, with minimal processing 
latencies. MR-Thermometry method was evaluated for liver and 
kidney of volunteers, and showed a precision of <2 °C in70 % of the 
pixels while delivering temperature and thermal dose maps on the fly.  
2) Intercostal HIFU firing to avoid excessive heating around the ribs. 
The ribs can be visualized on anatomical images acquired prior to 
heating and manually segmented. The resulting regions of interest are 
then projected on the transducer surface by ray tracing from the focal 
point. The transducer elements in the rib “shadow” are then deacti-
vated.  
3) Real Time MRI tracking of mobile targets for guidance of HIFU with 
sub-second 3D HIFU beam steering. The target position can be visua-
lized in 3D space by coupling rapid 2D MR imaging with prospective 
slice tracking based on pencil beam navigators 
In summary, MR guided HIFU is a promising alternative or complemen-
tary technology for ablation of tumors in many organs. It appears also 
feasible in liver and kidney but requires integration of technologically 
advanced methods.  
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Image registration - the fusion of volume image data sets acquired 
with different modalities or at different points in time - has become a 
vital tool for radiotherapy planning in cases where hybrid imaging 
techniques are not available or not feasible. Applications range from 
comparison of target volumes over time to multimodal image fusion, 
compensation of inter- and intrafractional target volume motion, 
adaptation of dose plans and precise patient setup in image-guided 
radiotherapy. The topic of this lecture is to introduce the basic me-
thods of image registration and to highlight the possibilities and 
limitations with a special view on the requirements of radiotherapy. 
An overview of clinical applications and research perspectives will be 
given.  
 
 
 
 
 
 
 
